Article
Genetic Progression of Pancreatic Cancer
1 Jan 2014
Abstract excerpt
The progression from normal cells to invasive pancreatic ductal adenocarcinoma (PDAC) requires the accumulation of multiple inherited or acquired mutations. Activating point mutations in the KRAS oncogene are prevalent in pancreatic cancer and result in the stimulation of several pathways including the RAF-mitogen-activated protein kinase pathway and the phosphoinositide 3-kinase pathway. Other genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
